{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:09:15Z","timestamp":1768536555830,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jdin.2024.02.007","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T17:39:47Z","timestamp":1708364387000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Severe cutaneous adverse reactions in a tertiary care center in Jamaica"],"prefix":"10.1016","volume":"15","author":[{"given":"Alicia J.S.","family":"McNish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6349-9668","authenticated-orcid":false,"given":"Althea D.C.","family":"East-Innis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdin.2024.02.007_bib1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4103\/0019-5154.147834","article-title":"Severe cutaneous adverse drug reactions: a clinicoepidemiological study","volume":"60","author":"Sasidharanpillai","year":"2015","journal-title":"Indian J Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2024.02.007_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2024.02.007_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/1574886315999200729144555","article-title":"A case of acute generalized exanthematous pustulosis by cefixime with oral mucosal involvement","volume":"15","author":"Namoju","year":"2020","journal-title":"Curr Drug Saf"},{"issue":"1-2","key":"10.1016\/j.jdin.2024.02.007_bib4","first-page":"37","article-title":"[Acute generalized exanthematic pustuloses (four cases) (author's transl)]","volume":"107","author":"Beylot","year":"1980","journal-title":"Ann Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jdin.2024.02.007_bib5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2133.2006.07284.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"155","author":"Peyri\u00e8re","year":"2006","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.02.007_bib6","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jdin.2024.02.007_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jdermsci.2020.09.009","article-title":"The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018","volume":"100","author":"Sunaga","year":"2020","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jdin.2024.02.007_bib8","series-title":"Cutaneous Drug Eruptions","first-page":"259","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis","author":"Klimas","year":"2015"},{"key":"10.1016\/j.jdin.2024.02.007_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jdin.2021.06.003","article-title":"The spectrum of skin diseases seen in a Jamaican tertiary academic medical center","volume":"4","author":"East-Innis","year":"2021","journal-title":"JAAD Int"},{"issue":"4","key":"10.1016\/j.jdin.2024.02.007_bib10","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2020.35.e17","article-title":"Adverse skin reactions with antiepileptic drugs using Korea adverse event reporting system database, 2008\u20132017","volume":"35","author":"Kim","year":"2020","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.jdin.2024.02.007_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/15569527.2021.1942896","article-title":"A review of published cases of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of acetaminophen","volume":"40","author":"Milosavljevi\u0107","year":"2021","journal-title":"Cutan Ocul Toxicol"},{"issue":"7","key":"10.1016\/j.jdin.2024.02.007_bib12","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jid.2016.03.023","article-title":"Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults","volume":"136","author":"Hsu","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jdin.2024.02.007_bib13","article-title":"Recent dermatological treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan","volume":"8","author":"Hsieh","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.jdin.2024.02.007_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/jamadermatol.2021.5390","article-title":"Clinical characteristics, disease course, and outcomes of patients with acute generalized exanthematous pustulosis in the US","volume":"158","author":"Creadore","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.02.007_bib15","first-page":"31","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"6","author":"Choudhary","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"issue":"9","key":"10.1016\/j.jdin.2024.02.007_bib16","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archderm.1991.01680080069004","article-title":"Acute generalized exanthematous pustulosis. Analysis of 63 cases","volume":"127","author":"Roujeau","year":"1991","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.02.007_bib17","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/bjd.12502","article-title":"Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients","volume":"169","author":"Hotz","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jdin.2024.02.007_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdin.2020.12.004","article-title":"Acute generalized exanthematous pustulosis: epidemiology, clinical course, and treatment outcomes of patients treated in an Asian academic medical center","volume":"3","author":"Oh","year":"2021","journal-title":"JAAD Int"},{"issue":"3","key":"10.1016\/j.jdin.2024.02.007_bib19","first-page":"281","article-title":"Acute generalized exanthematous pustulosis: report of five cases and systematic review of clinical and histopathological findings","volume":"149","author":"Vassallo","year":"2014","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jdin.2024.02.007_bib20","series-title":"Dermatology","first-page":"354","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS)","author":"Valeyrie-Allanore","year":"2018"},{"issue":"2","key":"10.1016\/j.jdin.2024.02.007_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clindermatol.2004.06.012","article-title":"Life-threatening acute adverse cutaneous drug reactions","volume":"23","author":"Wolf","year":"2005","journal-title":"Clin Dermatol"},{"issue":"12","key":"10.1016\/j.jdin.2024.02.007_bib22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen","year":"2010","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2024.02.007_bib23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1684\/ejd.2011.1550","article-title":"Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS)","volume":"21","author":"Wei","year":"2011","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2024.02.007_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergol Int"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328724000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T17:44:41Z","timestamp":1717436681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328724000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":24,"alternative-id":["S2666328724000245"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2024.02.007","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe cutaneous adverse reactions in a tertiary care center in Jamaica","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2024.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}